Difference between revisions of "Meningioma"
Jump to navigation
Jump to search
(+image, more) |
(→IHC: tweak, add refs) |
||
| Line 173: | Line 173: | ||
*S-100 +ve - [[schwannoma]]. | *S-100 +ve - [[schwannoma]]. | ||
**+ve in ~80% of fibrous meningiomas. | **+ve in ~80% of fibrous meningiomas. | ||
*CD34 +ve - solitary fibrous tumour. | *CD34 +ve - [[solitary fibrous tumour]]. | ||
**+ve in ~60% of fibrous meningiomas. | **+ve in ~60% of [[fibrous meningiomas]]. | ||
*EMA +ve in ~30% of hemangiopericytoma. | *EMA +ve in ~30% of hemangiopericytoma. | ||
*Claudin-1 - new kid on the block: +ve in meningioma, but low [[sensitivity]]. | *Claudin-1 - new kid on the block: +ve in meningioma, but low [[sensitivity]]. | ||
===Standard work-up (UHN) | ===Standard work-up (UHN)=== | ||
*Ki-67 >5-10% - predicts re-occurrence. | *Ki-67 >5-10% - predicts re-occurrence.<ref>Croul, SE. 8 November 2010.</ref> | ||
*PR (progesterone receptor) +ve in | *PR (progesterone receptor) +ve in > 80% of meningiomas.<ref>{{Cite journal | last1 = Takei | first1 = H. | last2 = Buckleair | first2 = LW. | last3 = Powell | first3 = SZ. | title = Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. | journal = Neuropathology | volume = 28 | issue = 1 | pages = 62-8 | month = Feb | year = 2008 | doi = 10.1111/j.1440-1789.2007.00852.x | PMID = 18021195 }}</ref> | ||
**Loss of PR staining predicts recurrence. | |||
**Strong association with tumour grade:<ref name=pmid22616825>{{Cite journal | last1 = Tao | first1 = Y. | last2 = Liang | first2 = G. | last3 = Li | first3 = Z. | last4 = Wang | first4 = Y. | last5 = Wu | first5 = A. | last6 = Wang | first6 = H. | last7 = Lu | first7 = Y. | last8 = Liu | first8 = Z. | last9 = Hu | first9 = G. | title = Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse. | journal = Br J Neurosurg | volume = | issue = | pages = | month = May | year = 2012 | doi = 10.3109/02688697.2012.685780 | PMID = 22616825 }}</ref> | |||
***Low WHO grade tumours usu. +ve. | |||
***High WHO grade tumours usu. -ve. | |||
==See also== | ==See also== | ||
Revision as of 19:18, 18 June 2012
Meningioma a very common tumour in neuropathology.
General
Prevalence
- Common.
- May be caused by prior radiation.
Radiology
- Extra-axial, intradural.
- Can be extradural - very rare.[1]
Prognosis
- Most are benign - usu. a good prognosis.
- May be malignant - bad prognosis.
Genetics
- May be seen in genetic disorders such as:
- Neurofibromatosis 2 (NF2).[2]
- Nevoid basal cell carcinoma syndrome (Gorlin syndrome).
- Cowden syndrome.
Microscopic
Features (memory device WCN):
- Whorled appearance - key feature.
- Calcification, psammomatous (target-like appearance; (tight) onion skin).
- +/-Nuclear pseudoinclusions - focal nuclear clearing with a sharp interface to unremarkable chromatin.
Images:
- WC:
- Meningioma with brain invasion - intermed. mag. (WC).
- Meningioma with brain invasion - high mag. (WC).
- www:
Notes:
- May involute into benign sclerotic tissue.[3]
- Thick-walled blood vessels = feature of schwannoma.
Morphologic subtypes
- Many subtypes exist.[4]
- The histologic subtypes generally don't have much prognostic significance.
- Some subtypes are high grade by definition; also see histologic grading.
Grade I
Meningothelial meningioma
- Most common.
Microscopic:
- Syncytial, nuclear clearing (pseudoinclusions).
Fibrous meningioma
- AKA fibroblastic.
- Not collagen but looks like it. (It is really laminin or fibronectin).
Transistional meningioma
- Rare.
Psammomatous meningioma
Microscopic:
Angiomatous meningioma
- AKA vascular.
- May bleed like stink.
Microcystic meningioma
Microscopic:
- Cystic appearance.
Secretory meningioma
- Associated with brain edema; may have a worse outcome.
Microscopic:[5]
- Eosinophilic intracytoplasmic inclusions that are CEA +ve and PAS +ve.
DDx:
- Metastatic mucinous adenocarcinoma.
Images:
Lymphoplasmacyte-rich meningioma
Microscopic:
- Lymphocytes.
- Plasma cells.
Images:
- Lymphoplasmacyte-rich meningioma - case 1 - several images (upmc.edu).
- Lymphoplasmacyte-rich meningioma - case 2 - several images (upmc.edu).
- Lymphoplasmacyte-rich meningioma - case 3 - several images (upmc.edu).
Metaplastic meningioma
- Much talked about... but very rare.
Microscopic:
- Cartilage or bone formation.
Grade II
Invasive meningioma
- Invades the brain.
Images:
Clear cell meningioma
Epidemiology:
- Usu. spinal cord.[7]
Microscopic:
- Clear cells - contain glycogen (PAS +ve).
Images:
Chordoid meningioma
- Chordoma-like.
Microscopic:
- Myxoid appearance.
Image:
Grade III
Papillary meningioma
Microscopic:
- True papillae.
Rhabdoid meningioma
Microscopic:
- Rhabdoid appearance (abundant cytoplasm).
- Cross-striations.
Images:
- Rhabdoid meningioma - case 1 - several images (upmc.edu).
- Rhabdoid meningioma - case 2 - several images (upmc.edu).
Histologic grading
Grading:[4]
- Grade 1:
- Low mitotic rate (< 4 mitoses/10 HPF - for whatever HPF means, see HPFitis).
- Excludes clear cell, chordoid, papillary, and rhabdoid subtypes.
- Grade 2 (either #1, #2 or #3):
- Brain-invasive meningioma.
- Protrusion of meningioma into brain.
- Meninogioma with entraped GFAP +ve tissue.
- Protrusion of meningioma into brain.
- Atypical meningioma (by histomorphology) - either A or B.
- A. Intermediate mitotic rate (>= 4 mitoses/10 HPF - for whatever HPF means, see HPFitis.)
- B. Three of the following five features:
- Clear cell or chordoid subtype.
- Brain-invasive meningioma.
- Grade 3 (either of the following):
- High mitotic rate (>=20 mitoses/10 HPF - for whatever HPF means, see HPFitis.)
- "Frank anaplasia"; marked nuclear atypia.
- Papillary or rhabdoid subtype.
Notes:
- Grade II soft criteria memory device HMNs: hypercellular, macronucleoli, NC ratio increased, necrosis, sheeting.
IHC
- EMA +ve.[8]
- Other CKs usually -ve.
DDx of meningioma & IHC[9]
- S-100 +ve - schwannoma.
- +ve in ~80% of fibrous meningiomas.
- CD34 +ve - solitary fibrous tumour.
- +ve in ~60% of fibrous meningiomas.
- EMA +ve in ~30% of hemangiopericytoma.
- Claudin-1 - new kid on the block: +ve in meningioma, but low sensitivity.
Standard work-up (UHN)
- Ki-67 >5-10% - predicts re-occurrence.[10]
- PR (progesterone receptor) +ve in > 80% of meningiomas.[11]
- Loss of PR staining predicts recurrence.
- Strong association with tumour grade:[12]
- Low WHO grade tumours usu. +ve.
- High WHO grade tumours usu. -ve.
See also
References
- ↑ URL: http://path.upmc.edu/cases/case702.html. Accessed on: 2 February 2012.
- ↑ URL: http://moon.ouhsc.edu/kfung/jty1/neurotest/Q13-Ans.htm. Accessed on: 26 October 2010.
- ↑ URL: http://radiographics.rsna.org/content/23/3/785.long. Accessed on: 3 November 2010.
- ↑ 4.0 4.1 Perry, Arie; Brat, Daniel J. (2010). Practical Surgical Neuropathology: A Diagnostic Approach: A Volume in the Pattern Recognition series (1st ed.). Churchill Livingstone. pp. 194. ISBN 978-0443069826.
- ↑ URL: http://moon.ouhsc.edu/kfung/jty1/Com04/Com405-1-Diss.htm. Accessed on: 12 October 2011.
- ↑ URL: http://moon.ouhsc.edu/kfung/jty1/Com04/Com405-1-Diss.htm. Accessed on: 3 January 2012.
- ↑ Perry, Arie; Brat, Daniel J. (2010). Practical Surgical Neuropathology: A Diagnostic Approach: A Volume in the Pattern Recognition series (1st ed.). Churchill Livingstone. pp. 200. ISBN 978-0443069826.
- ↑ Perry, Arie; Brat, Daniel J. (2010). Practical Surgical Neuropathology: A Diagnostic Approach: A Volume in the Pattern Recognition series (1st ed.). Churchill Livingstone. pp. 13. ISBN 978-0443069826.
- ↑ Hahn HP, Bundock EA, Hornick JL (February 2006). "Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics". Am. J. Clin. Pathol. 125 (2): 203–8. doi:10.1309/G659-FVVB-MG7U-4RPQ. PMID 16393681. http://ajcp.ascpjournals.org/content/125/2/203.full.pdf.
- ↑ Croul, SE. 8 November 2010.
- ↑ Takei, H.; Buckleair, LW.; Powell, SZ. (Feb 2008). "Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.". Neuropathology 28 (1): 62-8. doi:10.1111/j.1440-1789.2007.00852.x. PMID 18021195.
- ↑ Tao, Y.; Liang, G.; Li, Z.; Wang, Y.; Wu, A.; Wang, H.; Lu, Y.; Liu, Z. et al. (May 2012). "Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.". Br J Neurosurg. doi:10.3109/02688697.2012.685780. PMID 22616825.